Unrelated cord blood transplantation for an infant with chemotherapy-resistant progressive langerhans cell histiocytosis

American Journal of Pediatric Hematology/Oncology

Volumn 23, Issue 9, 2001, Pages 633-636

  Suminoe, Aiko ^a   Matsuzaki, Akinobu ^a   Hattori, Hiroyoshi ^a   Ishii, Sachiko ^b   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Cord blood transplantation; Langerhans cell histiocytosis; Organ dysfunction; Stem cell transplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISONE; THYMOCYTE ANTIBODY; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOLOGY; CANCER REGRESSION; CANCER RESISTANCE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HISTIOCYTOSIS X; HLA MATCHING; HUMAN; HUMAN TISSUE; INFANT; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; SKIN BIOPSY; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD TRANSPLANTATION; WHOLE BODY RADIATION;

6-MERCAPTOPURINE; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYTARABINE; DISEASE PROGRESSION; DOXORUBICIN; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; ETOPOSIDE; FETAL BLOOD; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; MALE; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISOLONE; REMISSION INDUCTION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VINCRISTINE;

EID: 0035696209     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200112000-00018     Document Type: Article

References (20)

1. Gadner H, Heitger A, Grois N, et al. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol 1994; 23: 72-80.
2. Grundy P, Ellis R. Histiocytosis X: a review of the etiology, pathology, staging, and therapy. Med Pediatr Oncol 1986; 14: 45-50.
3. Ceci A, de Terlizzi M, Colella R, et al. Langerhans cell histiocytosis in childhood: results from the Italian Cooperative AIEOP-CNR-H.X 83 study. Med Pediatr Oncol 1993; 21: 259-64.
4. Raney Jr, RB D’Angio GJ. Langerhans cell histiocytosis (histiocytosis X): experience at the Children’s Hospital of Philadelphia, 1970-1984. Med Pediatr Oncol 1989; 17: 20-8.
5. Lahey ME. Prognostic factors in histiocytosis X. Am J Pediatr Hematol Oncol 1981; 3: 57-60.
6. Rivera-Luna R, Alter-Molchadsky N, Cardenas-Cardos R, et al. Langerhans cell histiocytosis in children under 2 years of age. Med Pediatr Oncol 1996; 26: 334-43.
7. Braier J, Chantada G, Rosso D, et al. Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution. Pediatr Hematol Oncol 1999; 16: 377-85.
8. Stoll M, Freund M, Schmid H, et al. Allogeneic bone marrow transplantation for Langerhans cell histiocytosis. Cancer 1990; 66: 284-8.
9. Greinix HT, Storb R, Sanders JE, et al. Marrow transplantation for treatment of multisystem progressive Langerhans cell histiocytosis. Bone Marrow Transplant 1992; 10: 39-44.
10. Frost JD, Wiersma SR. Progressive Langerhans cell histiocytosis in an infant with Klinefelter syndrome successfully treated with allogeneic bone marrow transplantation. J Pediatr Hematol Oncol 1996; 18: 396-400.
11. Conter V, Reciputo A, Arrigo C, et al. Bone marrow transplantation for refractory Langerhans cell histiocytosis. Hematologica 1996; 81: 468-71.
12. Kinugawa N, Imashuku S, Hirota Y, et al. Hematopoietic stem cell transplantation (HSCT) for Langerhans cell histiocytosis (LCH) in Japan. Bone Marrow Transplant 1999; 24: 935-8.
13. Ayas M, Mustafa M, Al-Mahr M, et al. Bone marrow transplantation as a salvage therapy for refractory disseminated Langerhans histiocytosis [abstract]. Proceedings of the 14th Annual Meeting of the Histiocyte Society in Kyoto, Kyoto, Japan, Sept. 30-Oct. 2 1998: 36.
14. Nezelof C, Frileux-Herbet F, Cronier-Sachot J. Disseminated histiocytosis X: analysis of prognostic factors based on a retrospective study of 50 cases. Cancer 1979; 44: 1824-38.
15. Greenberger JS, Crocker AC, Vawter G, et al. Results of treatment of 127 patients with systemic histiocytosis (Letterer-Siwe syndrome, Schuller-Christian syndrome and multifocal eosinophilic granuloma). Medicine (Baltimore) 1981; 60: 311-38.
16. Philip Lanzkowsky. Histiocytosis syndromes. In: Manual of Pediatric Hematology and Oncology. Lanskowsky P, ed. New York: Churchill Livingstone, 2000: 571-98.
17. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565-77.
18. Matsuzaki A, Inamitsu T, Watanabe T, et al. Acute promyelocytic leukemia in a patient treated with etoposide for Langerhans cell histiocytosis. Br J Haematol 1994; 86: 887-9.
19. Ladisch S, Gadner H, Arico M, et al. LCH-1: a randomized trial of etoposide versus vinblastine in disseminated Langerhans cell histiocytosis. Histiocyte Society Group. Med Pediatr Oncol 1994; 23: 107-10.
20. Arceci RJ, Brenner MK, Pritchard J. Controversies and new approaches to treatment of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998; 12: 339-57.